• Latest Posts
In Depth 23 Nov 2023

The next frontier in immunotherapy? CAR-Macrophages as a novel cancer treatment strategy

In Depth 22 Nov 2023

Apellis’ Syfovre vs Astellas’ Izervay: the battle for a geographic atrophy treatment

Beyond insulin: six cutting-edge diabetes biotech companies you should know about

M&As: what’s up with the ADC buying spree?

With $700 million Q3 rise, U.K. biotech spearheads European recovery

Podcast 17 Nov 2023

How can life-saving vaccines be more affordable?

ADVERTISEMENT
In Depth 16 Nov 2023

Meet the ‘biotech mafia’: how specialized biotech VC firms are dominating industry funding once again

In Depth 15 Nov 2023

Beyond oil and gas: Biotech’s significant place in the Qatar Investment Authority’s strategy

10 biotech companies leading innovation in the Asia-Pacific region

Weekly Roundup 10 Nov 2023

Korro Bio and Frequency’s merger; Lexeo’s $100 million IPO; Gate Biosciences new class of drugs

Podcast 10 Nov 2023

How biotech can mend a broken heart

ADVERTISEMENT